SCLEROSIS, PROGRESSIVE SYSTEMIC

Clinical trials for SCLEROSIS, PROGRESSIVE SYSTEMIC explained in plain language.

Never miss a new study

Get alerted when new SCLEROSIS, PROGRESSIVE SYSTEMIC trials appear

Sign up with your email to follow new studies for SCLEROSIS, PROGRESSIVE SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could ifetroban ease scleroderma lung damage?

Disease control Ongoing

This study tests an experimental drug called ifetroban in people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis) or scleroderma-related high blood pressure in the lungs. The goal is to see if the drug is safe and can improve lung function. About 34 adults…

Matched conditions: SCLEROSIS, PROGRESSIVE SYSTEMIC

Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control

Last updated May 05, 2026 11:55 UTC

SCLEROSIS, PROGRESSIVE SYSTEMIC

Get alerted when new SCLEROSIS, PROGRESSIVE SYSTEMIC trials appear

Could ifetroban ease scleroderma lung damage?